2012 : « Best European Equity earning forecast » according to AQ Research
2009-2011 : « Best European Equity research » according to AQ Research
2011 Fourth Quarter : « Best European Equity research » according to AQ Research
2011 Third Quarter : « Best European Equity research » according to AQ Research
2011 First Quarter : « Second European Equity research » according to AQ Research
2011 : Nominated « Best equity research of the year » according to The Technical Analyst
2010 Second Quarter : « Best European Equity research » according to AQ Research
2010 First Quarter : « Third European Equity research » according to AQ Research
2010 : Nominated « Best technical Analyst of the year » according to The Technical Analyst
2010 : Nominated « Best equity research of the year » according to The Technical Analyst
2009 Fourth Quarter : « Best European Equity research » according to AQ Research
2009 Third Quarter : « Best European Equity research » according to AQ Research
2009 Second Quarter : « Third European Equity research » according to AQ Research
2009 : Nominated « Best technical Analyst of the year » according to The Technical Analyst
2009 : Nominated « Best equity research of the year » according to The Technical Analyst
21/02/2012
Source : Reuters lire le PDF
Shares in Fresenius Medical Care fall 1.1 percent in robust volume, extending losses into a fourth straight session and underperforming a 0.2 percent rise for the European healthcare sector, after the world's largest dialysis company reports slightly disappointing earnings.
The introduction of a new reimbursement system in the United States, designed to encourage clinic operators to reduce costs and use drugs more sparingly, resulted in lighter-than-expected U.S. revenue per treatment for the German group, JPMorgan says.